Mycotoxin Symptoms: The Complete Guide to Recognizing What Mold Is Doing to Your Body

You know something is wrong. Maybe it started with brain fog that made you feel like you were thinking through wet concrete. Maybe it was the fatigue — the kind that sleep does nothing for. Maybe it was the strange combination of symptoms that doesn't fit any diagnosis: joint pain plus anxiety plus digestive issues plus that weird skin rash that comes and goes.

You've been to doctors. Maybe several. You've heard "your labs look normal" and "have you considered that it might be stress?" You've googled your symptoms at 3am and found everything from autoimmune disease to chronic fatigue to "anxiety presenting physically."

And then someone mentioned mold. Or you remembered that your apartment had a leak last year. Or you noticed that musty smell in the office you can't quite place. And now you're searching "mycotoxin symptoms" because you need to know: Could this actually be mold poisoning?

Here's what the research actually shows about how mycotoxins affect the body, why symptoms vary so dramatically between people, and how to distinguish mycotoxin illness from the dozens of conditions it mimics.

What Mycotoxins Actually Are

Mycotoxins aren't mold itself. They're toxic compounds that certain molds produce as metabolic byproducts — chemical weapons, essentially, that help fungi compete against bacteria and other organisms in their environment.

More than 300 mycotoxins have been identified, produced by various species of fungi. But when it comes to human illness from indoor mold exposure, several types dominate the clinical picture:

The Major Players

Aflatoxins: Produced primarily by Aspergillus flavus and Aspergillus parasiticus. The most studied mycotoxins globally, classified as Group 1 carcinogens (definitively cancer-causing) by the International Agency for Research on Cancer. Aflatoxin B1 specifically targets the liver and is associated with hepatocellular carcinoma. In indoor environments, aflatoxins are less common than other mycotoxins but can occur in water-damaged buildings with Aspergillus growth.

Ochratoxin A (OTA): Produced by Aspergillus and Penicillium species — common indoor molds. Ochratoxin A primarily targets the kidneys but has documented effects on the immune system and nervous system. It's lipophilic (fat-loving), meaning it accumulates in fatty tissues and has a long half-life in the body.

Trichothecenes: A family of over 200 related compounds produced by Fusarium, Stachybotrys (the infamous "black mold"), and other species. Trichothecenes are among the most toxic mycotoxins and affect protein synthesis at the cellular level. They're potent immunosuppressants. Satratoxins, macrocyclic trichothecenes produced by Stachybotrys chartarum, are particularly concerning in water-damaged buildings.

Gliotoxins: Produced by Aspergillus fumigatus and some Penicillium species. These immunosuppressive compounds interfere with immune cell function and can persist in the body.

Fumonisins: Primarily produced by Fusarium species on corn and grain. Less common in indoor settings but relevant for people with dietary mycotoxin exposure.

Zearalenone: An estrogenic mycotoxin that can disrupt hormonal function. Produced by Fusarium species.

How Mycotoxins Enter Your Body

Mycotoxins can enter through three routes:

Inhalation: The primary concern with water-damaged buildings. Mycotoxins attach to mold spores, fragments, and fine particulate matter that become airborne. The particles don't have to be whole spores — dead mold fragments still carry mycotoxins and can be inhaled deep into the lungs. Particles under 2.5 microns reach the alveoli (tiny air sacs) where they can enter the bloodstream.

Ingestion: Low levels of mycotoxins contaminate many foods — the WHO estimates mycotoxins affect roughly 25% of the world's crops. Cereals, coffee, wine, peanuts, dried fruits, and spices are common sources. For most people, dietary exposure causes no obvious symptoms. For those with impaired detoxification or high total load, dietary mycotoxins add to the burden.

Dermal absorption: Mycotoxins can absorb through skin, though this route is typically less significant than inhalation for indoor exposure. It becomes relevant for people handling heavily contaminated materials.

The key insight: you don't need to see mold or smell must to be exposed. Mycotoxins are invisible, odorless, and can persist in environments long after the visible mold is cleaned.

Symptoms by Body System

Mycotoxin illness doesn't present like a typical infection with clear, localized symptoms. It's a systemic condition — the toxins circulate throughout the body and affect multiple organ systems simultaneously.

This multi-system involvement is actually one of the diagnostic clues. If someone has symptoms spanning five or more body systems with no clear explanation, mycotoxin exposure belongs on the differential.

Neurological Symptoms

The brain is particularly vulnerable to mycotoxins for two reasons: it's largely composed of fat (where lipophilic mycotoxins accumulate), and the blood-brain barrier can be compromised by chronic inflammation.

Brain fog is the symptom people describe most often. Not just "tired" or "distracted" — a qualitative change in cognitive function. Thoughts feel sluggish. Word-finding becomes difficult. Reading comprehension drops. You read the same paragraph multiple times. You walk into rooms and forget why.

Memory problems that feel different from normal forgetting. Short-term memory particularly affected. Names, appointments, recent conversations lost.

Difficulty concentrating that doesn't respond to caffeine or willpower. The ability to sustain focus for extended periods vanishes.

Disorientation and spatial confusion. Getting lost in familiar places. Difficulty navigating.

Headaches — often pressure-type, sometimes migraine-like. May correlate with time spent in contaminated environments.

Dizziness and vertigo. The room spins or feels unstable. Balance affected.

Light sensitivity (photophobia). Bright lights feel painful or trigger headaches.

Tremors or unexplained muscle twitching.

Mood changes: anxiety, depression, irritability that started without clear psychological trigger. Some patients report intrusive thoughts or cognitive patterns that feel foreign.

Sleep disturbances: inability to fall asleep, waking throughout the night, non-restorative sleep, vivid or disturbing dreams.

Respiratory Symptoms

The respiratory system takes the first hit with inhaled mycotoxins.

Chronic sinusitis that doesn't respond to standard treatments. Recurring sinus infections. Persistent post-nasal drip.

Shortness of breath without clear cause. Exercise intolerance. The sensation of not getting enough air.

Chronic cough — often dry, sometimes with mucus production. Cough that persists long after any "cold" should have resolved.

Wheezing or chest tightness. Asthma-like symptoms that may develop without prior asthma history.

Frequent respiratory infections. The immune suppression from mycotoxins makes opportunistic infections more likely.

Nosebleeds in some cases.

Digestive Symptoms

Mycotoxins disrupt gut function directly and indirectly through their effects on the immune system and bile acid metabolism.

Chronic nausea without vomiting. Food aversion. Everything feels slightly sickening.

Abdominal pain and cramping. Often diffuse, not localized to one area.

Bloating that seems unrelated to food intake.

Diarrhea, constipation, or alternating between both. IBS-like presentation.

New food sensitivities that develop without explanation. Foods that were previously fine suddenly cause reactions.

Appetite changes — either loss of appetite or unusual cravings.

Musculoskeletal Symptoms

Joint pain without swelling or obvious inflammation. Migratory — moves between joints.

Muscle aches and weakness. The feeling of having run a marathon without having exercised.

Morning stiffness that takes hours to resolve.

Muscle cramps and spasms.

Skin Symptoms

Skin is an elimination organ. When the primary detox pathways (liver, kidneys, bowels) are overloaded, toxins exit through skin.

Rashes that come and go without clear trigger. Often not responding to topical treatments.

Hives or urticaria.

Increased bruising in some cases.

Slow wound healing.

Unusual skin sensations — crawling feelings, tingling, burning.

Cardiovascular Symptoms

Heart palpitations and irregular heartbeat. Can feel like skipped beats or racing heart.

Chest tightness (distinct from the respiratory chest tightness).

Blood pressure fluctuations.

Hormonal/Endocrine Symptoms

Several mycotoxins directly affect hormone production and regulation.

Fatigue that's disproportionate to activity and unrelieved by rest. This is the fatigue that sleep doesn't fix — it's present upon waking.

Temperature dysregulation. Feeling cold when others are comfortable. Hot flashes. Difficulty adapting to temperature changes.

Thyroid dysfunction — often subclinical (labs borderline but not flagged).

Reproductive issues: irregular cycles, worsened PMS, decreased libido, erectile dysfunction, fertility problems. Zearalenone specifically has estrogenic effects.

Night sweats without fever.

Immune System Effects

Multiple chemical sensitivity (MCS) — new reactions to perfumes, cleaning products, car exhaust, and other chemicals that previously didn't bother you. The immune system becomes hyperreactive.

Increased susceptibility to infections. Getting every cold that circulates. Infections lasting longer than normal.

Paradoxically, autoimmune-like symptoms can develop. The immune system becomes both suppressed (against pathogens) and dysregulated (attacking self).

Mast cell activation — histamine intolerance, flushing, allergic-type reactions without clear allergens.

Why Symptoms Vary So Dramatically Between People

Two people can live in the same water-damaged building. One develops debilitating multi-system illness. The other feels fine. This isn't psychological — it's biological.

HLA Genetics: The Susceptibility Factor

The Human Leukocyte Antigen (HLA) system is a family of genes on chromosome 6 that regulate immune responses. Specific variants of HLA-DR and HLA-DQ affect how the body recognizes and clears biotoxins.

About 24% of the population carries HLA gene variants associated with difficulty clearing mold and other biotoxins. In these individuals, the immune system doesn't properly tag mycotoxins for removal. Instead of being recognized, bound, and eliminated, the toxins circulate. The immune system keeps responding to them. Chronic inflammation results.

This explains a striking clinical observation: approximately 90% of patients seeking evaluation for mold-related illness have susceptible HLA types. The 76% of the population without these variants typically clears mycotoxins efficiently and doesn't develop chronic symptoms from the same exposures.

HLA susceptibility isn't binary — some variants confer higher risk than others. Multiple susceptible variants compound risk. Some HLA types are associated with specific responses (mold vs. Lyme vs. multiple biotoxins).

Total Toxic Load

Mycotoxins don't exist in isolation. The "total load" theory recognizes that the body has finite detoxification capacity. When multiple toxins compete for the same clearance pathways, all of them clear more slowly.

Factors that increase total load:

Heavy metal exposure (mercury, lead, etc.)
Chronic infections (Lyme, viral reactivations)
Environmental chemicals (pesticides, plasticizers)
Poor air quality
Mold from multiple sources
Dietary mycotoxins

Someone with low total load might tolerate moderate mycotoxin exposure without obvious symptoms. The same exposure in someone with high total load tips them into illness.

Individual Detoxification Capacity

Beyond HLA genetics, multiple factors affect how efficiently you process and eliminate toxins:

Glutathione status: Glutathione is the body's master antioxidant and crucial for mycotoxin detoxification. Depleted glutathione (from chronic stress, infections, poor nutrition, or genetic variants like GSTM1/GSTT1 deletions) impairs clearance.

Methylation capacity: The methylation cycle supports detoxification. MTHFR and related genetic variants can reduce methylation efficiency.

Liver function: The liver transforms mycotoxins for elimination. Any liver burden (alcohol, medications, infections) reduces capacity.

Gut health: Damaged gut lining increases absorption and reduces elimination of toxins. Bile flow is crucial — many mycotoxins are eliminated via bile.

Kidney function: Ochratoxin A specifically depends on kidney elimination.

Exposure Variables

Type of mycotoxin: Different mycotoxins have different toxicity profiles. Trichothecenes are acutely more toxic than ochratoxin, which causes more chronic accumulation.

Concentration and duration: Low-level chronic exposure creates different patterns than high-level acute exposure.

Route of exposure: Inhalation delivers mycotoxins directly to lungs and rapidly to bloodstream. Ingestion allows some first-pass metabolism in the liver.

Source still present vs. removed: Ongoing exposure prevents any recovery attempt from succeeding.

Acute vs. Chronic Exposure: Different Symptom Patterns

Acute Exposure

Acute mycotoxin poisoning from massive exposure is rare in developed countries but documented historically (outbreaks from contaminated grain) and occupationally (agricultural workers, remediation workers without proper protection).

Acute symptoms can include:

Severe gastrointestinal distress (vomiting, diarrhea, abdominal pain)
Hemorrhaging (trichothecenes particularly)
Liver damage (aflatoxins)
Neurological crisis
Immune suppression

This presentation is obviously medical and usually gets treated as poisoning.

Chronic Low-Level Exposure

This is the more common — and more insidious — pattern. Chronic exposure from living or working in water-damaged buildings produces:

Gradual onset: Symptoms develop over weeks to months. No clear "I was fine, then I got sick" moment.

Fluctuating severity: Symptoms wax and wane. Good days and bad days. This makes pattern recognition difficult.

Multi-system involvement: The symptom list grows over time as more systems become affected.

Correlation with environment: Symptoms may improve on vacation, worsen on return, but the connection isn't always obvious (especially if there's a delay between exposure and symptoms).

Accumulating damage: If exposure continues, symptoms generally worsen over time as toxic load builds and inflammatory cascades become self-perpetuating.

What Mycotoxin Illness Gets Misdiagnosed As

Mycotoxin symptoms overlap with dozens of conditions. This isn't coincidental — many of these conditions share inflammatory mechanisms with mycotoxin illness, and some may actually be triggered or worsened by mycotoxin exposure.

Common Misdiagnoses

Condition	Why It's Confused	Key Difference
Chronic Fatigue Syndrome (ME/CFS)	Fatigue, post-exertional malaise, cognitive dysfunction	Mycotoxin illness has environmental trigger; may have different inflammatory markers
Fibromyalgia	Widespread pain, fatigue, cognitive issues	Same overlap; some researchers believe mold may trigger some fibromyalgia cases
Depression/Anxiety	Mood changes, fatigue, cognitive issues	Mycotoxin mood changes often accompanied by physical symptoms; may not respond to psychiatric medication
Irritable Bowel Syndrome (IBS)	Digestive symptoms	Mycotoxin GI symptoms occur alongside multi-system involvement
Allergies/Allergic Rhinitis	Respiratory symptoms, sinus issues	Mold allergy is different from mycotoxin poisoning; both can coexist
Hypothyroidism	Fatigue, weight changes, cognitive fog	Labs may be borderline in mycotoxin illness but classic hypothyroidism pattern absent
Multiple Sclerosis	Neurological symptoms, brain fog, visual changes	MRI findings differ; mycotoxin illness has different inflammatory profile
Lyme Disease	Overlapping symptoms, multi-system	Can coexist; different triggers but often similar inflammatory patterns (C3a elevation more specific to Lyme)
Lupus/Autoimmune	Joint pain, fatigue, multi-system	Can overlap; mycotoxin illness may trigger or worsen autoimmunity
"Stress" or "It's All in Your Head"	No obvious explanation on standard testing	The most frustrating misdiagnosis; comes from practitioners unfamiliar with CIRS

The "Normal Labs" Problem

Standard medical workups often miss mycotoxin illness because they're looking at the wrong markers. A complete blood count, basic metabolic panel, and thyroid panel will usually be normal or borderline. These tests weren't designed to detect biotoxin-induced inflammation.

This leads to the experience many patients describe: "My doctor says my labs are normal but I know something is wrong." The labs are normal — for what they're testing. They're just not testing for the condition that's present.

Testing Options: What's Available and What It Actually Tells You

Testing for mycotoxin illness falls into three categories: testing the environment, testing for mycotoxins in the body, and testing for the inflammatory response mycotoxins cause.

Environmental Testing

ERMI (Environmental Relative Moldiness Index): DNA-based analysis of settled dust. Identifies 36 mold species and generates a score comparing your environment to a reference set. Developed by the EPA. Useful for identifying water-damaged buildings but doesn't directly measure mycotoxin levels.

HERTSMI-2: A subset of ERMI focusing on five species most associated with water damage and illness. Shoemaker's protocol uses HERTSMI-2 scores under 11 as the threshold for safe environments.

Air sampling: Captures airborne mold spores. Limited because it only captures what's airborne at that moment and doesn't detect dead mold or fragments (which still carry mycotoxins).

Visual inspection with moisture meters and thermal imaging: Often most practical first step. Water damage creates mold. Finding the water damage matters.

Urine Mycotoxin Testing

What it is: Several labs (RealTime Laboratories, Great Plains Laboratory/Mosaic, Vibrant Wellness) offer urine tests that detect specific mycotoxins.

The controversy: This is where things get contentious.

The CDC and conventional medical establishment position: There is no FDA-approved test for mycotoxins in human urine. The CDC does not recommend biologic testing of persons who work or live in water-damaged buildings. A 2015 CDC MMWR publication specifically criticized unvalidated urine mycotoxin testing, noting that "mycotoxin levels that predict disease have not been established" and that low levels of mycotoxins are found in the urine of healthy persons from dietary exposure.

The clinical practitioner position: Many functional and integrative medicine practitioners use urine mycotoxin testing regularly and find clinical utility in it. They argue that while the tests may not be FDA-approved, they use validated analytical chemistry (mass spectrometry, ELISA) and provide useful information about toxin load.

The practical reality:

Positive results may reflect dietary mycotoxin exposure, not building exposure
Results can vary between labs using different methodologies (RealTime uses ELISA; Great Plains/Mosaic uses mass spectrometry; they're measuring different things)
A negative test doesn't rule out mycotoxin illness (mycotoxins may be sequestered in tissue rather than excreted)
A positive test doesn't confirm that mycotoxins are causing current symptoms
"Reference ranges" on these tests are set by the labs themselves, not established through large population studies
Provocation (taking glutathione or sauna before testing) may increase detection but also increases false positives

What practitioners actually do with the results: Use them as one data point alongside clinical history, environmental history, and inflammatory markers. A high ochratoxin with known water damage, susceptible HLA, elevated inflammatory markers, and matching symptoms is clinically meaningful even if not FDA-validated.

Blood Inflammatory Markers (CIRS Panel)

These markers test the inflammatory response rather than the mycotoxins themselves. Dr. Ritchie Shoemaker developed this panel over decades of clinical work.

Marker	Normal Range	What It Indicates
C4a	<2,830 ng/mL	Complement activation from biotoxins. Often dramatically elevated (10,000-20,000+) in active CIRS. Most specific marker for biotoxin inflammation.
C3a	<780 ng/mL	Complement activation. Elevated more specifically with bacterial infection (like Lyme). Normal or borderline in pure mold cases.
TGF-beta1	<2,380 pg/mL	Cytokine involved in tissue remodeling and fibrosis. Associated with respiratory symptoms, autoimmune-like symptoms.
MMP-9	<332 ng/mL	Matrix metalloproteinase. Elevated indicates tissue breakdown and blood-brain barrier compromise. Associated with cognitive symptoms.
MSH	35-81 pg/mL	Melanocyte-stimulating hormone. Often low in CIRS. Affects pain perception, inflammatory regulation, mucus membrane defense.
VIP	23-63 pg/mL	Vasoactive intestinal peptide. Often low. Affects multiple regulatory functions.
ADH + Osmolality	Compared together	Abnormal ratios indicate hypothalamic disruption affecting fluid balance.
VEGF	31-86 pg/mL	Vascular endothelial growth factor. Abnormal levels affect oxygen delivery.
Leptin	Sex/BMI specific	Often elevated. Affects appetite, metabolism, inflammation.

Genetic Testing

HLA-DR/DQ: Identifies genetic susceptibility to biotoxin illness. Doesn't diagnose current illness but helps explain why you might be affected when others aren't. About 24% of population has susceptible variants.

Visual Contrast Sensitivity (VCS) Testing

What it is: A functional test measuring the ability to distinguish between different shades of gray at varying spatial frequencies. Requires only a computer screen or printed chart.

Why it matters: Biotoxins impair neurological function in ways that affect visual processing. VCS testing is abnormal in approximately 92% of CIRS patients and normalizes with successful treatment.

Limitations: Not specific to mold — other toxins, neurodegenerative conditions, and some medications also affect VCS. Most useful as screening and monitoring tool, not definitive diagnosis.

When to Suspect Mycotoxins

Mycotoxin illness should be on your radar if:

1. Multi-system symptoms without explanation. More than three body systems affected (neurological, respiratory, digestive, musculoskeletal, skin, etc.) with no unifying diagnosis.

2. Environmental history. Current or recent exposure to water-damaged building — visible mold, water stains, musty odor, known leaks, flooding history, humid climate. Includes home, workplace, school, car, or frequently visited buildings.

3. Symptoms that fluctuate with environment. Feeling better on vacation, away from home, or outdoors. Symptoms worsening in specific buildings.

4. Onset correlating with move, renovation, or water event. Symptoms starting within weeks to months of moving to a new home, having construction/renovation work, or experiencing water damage.

5. Treatment resistance. Standard treatments for diagnosed conditions not working. Infections that keep recurring. Therapies that should help but don't.

6. Multiple household members affected. If others in the same environment have overlapping symptoms, environmental cause becomes more likely.

7. Failed previous diagnoses. Being told you have fibromyalgia, chronic fatigue, IBS, anxiety, depression — but treatments for those conditions don't work.

8. The "I've been sick since..." pattern. A clear before/after with no obvious infection or event, correlating with environmental change.

What Mycotoxin Symptoms Are NOT

Understanding what symptoms are NOT typically mycotoxin-related helps avoid misattribution.

Acute localized infection: A clear bacterial infection with fever, localized swelling, obvious source is probably infection, not mycotoxin.

Symptoms only when eating specific foods: Food allergies or intolerances, not necessarily mycotoxins (though dietary mycotoxins can contribute to total load).

Symptoms that completely resolve within hours of leaving an environment: More likely mold allergy (IgE-mediated) than mycotoxin illness. Mycotoxin illness persists because the toxins are in you, not just around you.

Single-system symptoms with no other complaints: While mycotoxin illness can be dominated by one system initially, purely isolated symptoms are less characteristic.

What to Do If You Suspect Mycotoxins

Step 1: Investigate Your Environment

Before spending thousands on testing, investigate whether you actually have exposure.

Look for visible mold, water stains, musty odors
Check areas where water intrusion is common: around windows, under sinks, basement/crawl space, roof leaks, HVAC system
Consider professional inspection with moisture meters and thermal imaging
Consider ERMI or HERTSMI-2 testing if visual inspection is inconclusive

Step 2: Track Symptom Patterns

Keep a log of symptoms and note:

Do symptoms improve when you're away for 3+ days?
Are symptoms worse in certain buildings?
When did symptoms start? What changed in your environment around that time?

Step 3: Find an Informed Practitioner

Look for practitioners with training in:

CIRS/biotoxin illness (Shoemaker-trained)
Environmental medicine
Functional medicine with environmental focus

Organizations like ISEAI (International Society for Environmentally Acquired Illness) certify practitioners. Dr. Shoemaker's SurvivingMold.com has a practitioner directory.

Step 4: Consider Testing (With Appropriate Expectations)

If budget is limited: VCS testing is free online. Environmental testing (ERMI) is relatively affordable ($150-300). These give useful initial information.

If pursuing full evaluation: Full CIRS inflammatory panel, HLA testing, and clinical evaluation with knowledgeable practitioner provides most complete picture. Urine mycotoxin testing is optional and controversial — discuss with your practitioner.

Step 5: Address Exposure First

No treatment protocol works if you're still exposed. This is the hardest and most important step. It may mean leaving a home, changing jobs, or making expensive remediation decisions.

The Honest Limitations

No FDA-approved testing exists. Urine mycotoxin testing is not validated by conventional standards. Blood inflammatory markers are accepted in the CIRS-aware community but not mainstream medicine.

Many doctors don't recognize this condition. CIRS is not taught in most medical schools. You may encounter dismissal or skepticism from conventional practitioners.

Treatment is complex and individual. There's no quick fix. Protocols like the Shoemaker Protocol take months to years. Not everyone recovers fully.

Environmental remediation is expensive. Properly addressing water-damaged buildings can cost thousands to tens of thousands of dollars. Some people have to leave homes or jobs.

Research is limited. While clinical experience is substantial, large controlled studies are lacking. This is partly why conventional medicine remains skeptical.

Symptoms overlap with many conditions. Mycotoxin illness is not always the answer. Over-attribution is as problematic as under-recognition.

The Bottom Line

Mycotoxin symptoms are real, documented, and often devastating for those affected. They arise from the interaction between mycotoxin exposure, individual genetic susceptibility, and the complex inflammatory cascades that result.

If you recognize this pattern — multi-system symptoms that doctors can't explain, environmental history that fits, improvement when away from certain buildings — it's worth investigating. You're not crazy. Your labs might be "normal" for what they're testing while your body is fighting a battle standard medicine isn't looking for.

At the same time, mycotoxin illness isn't behind every mysterious symptom. The path forward requires careful investigation of environment, appropriate testing with appropriate expectations, and ideally working with a practitioner who understands this terrain.

Start with your environment. If you find water damage or mold, you have your answer about exposure. What you do from there is between you and practitioners who know how to help.